Related references
Note: Only part of the references are listed.Updates on eosinophilic disorders
Alexandar Tzankov et al.
VIRCHOWS ARCHIV (2023)
Plasmacytoid dendritic cells in the setting of myeloid neoplasms: Diagnostic guide to challenging pathologic presentations
Siba El Hussein et al.
BRITISH JOURNAL OF HAEMATOLOGY (2023)
Myeloproliferative Neoplasms with Monocytosis
Erika Morsia et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2022)
Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients
Mahsa Khanlari et al.
LEUKEMIA (2022)
Bone marrow fibrosis impact on response to azacitidine in myelodysplastic syndromes
Roya Shahidi et al.
PATHOLOGY (2022)
Myelodysplastic Syndromes with Bone Marrow Fibrosis : An Update
Akriti G. Jain et al.
ANNALS OF LABORATORY MEDICINE (2022)
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber et al.
BLOOD (2022)
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics
Ijele J. Adimora et al.
CANCER (2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury et al.
LEUKEMIA (2022)
Bone Marrow Fibrosis at Diagnosis and during the Course of Disease Is Associated with TP53 Mutations and Adverse Prognosis in Primary Myelodysplastic Syndrome
Youshan Zhao et al.
CANCERS (2022)
Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum
Xavier Calvo et al.
BLOOD ADVANCES (2022)
Accelerated and blast phase myeloproliferative neoplasms
Antoine N. Saliba et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2022)
High frequency of clonal hematopoiesis in Erdheim-Chester disease
Fleur Cohen Aubart et al.
BLOOD (2021)
Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) andSF3B1
Chi Young Ok et al.
MODERN PATHOLOGY (2021)
Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation
Paul G. Kemps et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2021)
Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progression
Stephan Bartels et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms
Mattia Schino et al.
HAEMATOLOGICA (2021)
MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia
Arturo Bonometti et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2021)
Genomic analysis in myeloid sarcoma and comparison with paired acute myeloid leukemia
Nancy Y. Greenland et al.
HUMAN PATHOLOGY (2021)
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases
Naseema Gangat et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies
Magdalena M. Brune et al.
CANCERS (2021)
Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin
Kiran Batta et al.
LEUKEMIA (2021)
Targeting CD123 in hematologic malignancies: identifying suitable patients for targeted therapy
Mrinal M. Patnaik et al.
LEUKEMIA & LYMPHOMA (2021)
Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
Laura Palomo et al.
CANCERS (2021)
IRF8 is a Reliable Monoblast Marker for Acute Monocytic Leukemias
Samuel G. Katz et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Moderate to Severe Marrow Fibrosis As a More Advanced Risk Factor for MDS and MDS-AML Patients With Excess of Blasts Receiving Allogeneic Hematopoietic Stem Cell Transplantation
Jiali Wang et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Newly diagnosed isolated myeloid sarcoma-paired NGS panel analysis of extramedullary tumor and bone marrow
Nils W. Engel et al.
ANNALS OF HEMATOLOGY (2021)
Cutaneous-group histiocytoses associated with myeloid malignancies: A systematic review of 102 cases
Arturo Bonometti et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2021)
Progression, transformation, and unusual manifestations of myelodysplastic syndromes and myelodysplastic-myeloproliferative neoplasms: lessons learned from the XIV European Bone Marrow Working Group Course 2019
Konnie Hebeda et al.
ANNALS OF HEMATOLOGY (2021)
Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia
Janghee Woo et al.
HAEMATOLOGICA (2020)
Myeloid neoplasms with isolated del(5q) and JAK2 V617F mutation: a grey zone combination of myelodysplastic and myeloproliferative features?
Valentina F. I. Sangiorgio et al.
HAEMATOLOGICA (2020)
The Molecular Genetics of Myeloproliferative Neoplasms
Anna E. Marneth et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
Mutations associated with age-related clonal hematopoiesis in PMF patients with rapid progression to myelofibrosis
Stephan Bartels et al.
LEUKEMIA (2020)
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature
Giacomo Coltro et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2020)
Decoding Bone Marrow Fibrosis in Myelodysplastic Syndromes
Megan Melody et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Molecular Discordance between Myeloid Sarcomas and Concurrent Bone Marrows Occurs in Actionable Genes and Is Associated with Worse Overall Survival
Brian Werstein et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2020)
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients
Giacomo Coltro et al.
LEUKEMIA (2020)
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms
Laura Palomo et al.
BLOOD (2020)
Co-existence of mutations in myeloproliferative neoplasms and their clinical significance: a prognostic approach
Elham Homaei Hadad et al.
EXPERT REVIEW OF HEMATOLOGY (2020)
Cytokine Profiling in Myeloproliferative Neoplasms: Overview on Phenotype Correlation, Outcome Prediction, and Role of Genetic Variants
Elena Masselli et al.
CELLS (2020)
Outcome of patients with IDH1/2-mutated post myeloproliferative neoplasm AML in the era of IDH inhibitors
Helen T. Chifotides et al.
BLOOD ADVANCES (2020)
Does the order of mutational acquisition in myeloproliferative neoplasms matter? Evidence from JAK2 exon 12 and DNMT3A co-mutant polycythemia vera
Rumyana Todorova et al.
JOURNAL OF HEMATOPATHOLOGY (2020)
Many faces of the same myeloid neoplasm: a case of leukaemia cutis with mixed histiocytic and Langerhans cell differentiation
Vignesh Shanmugam et al.
JOURNAL OF CLINICAL PATHOLOGY (2019)
Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia
Nolwenn Lucas et al.
LEUKEMIA (2019)
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
Rory M. Shallis et al.
BLOOD REVIEWS (2019)
The emergence of a JAK2 V617F-mutated clone in myelodysplastic syndrome is associated with disease progression and features of myelofibrosis
Boris Zhong et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
Peter Valent et al.
HAEMATOLOGICA (2019)
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Commonly Presents in the Setting of Prior or Concomitant Hematologic Malignancies (PCHM): Patient Characteristics and Outcomes in the Rapidly Evolving Modern Targeted Therapy Era
Naveen Pemmaraju et al.
BLOOD (2019)
The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14
Beatrice Drexler et al.
HAEMATOLOGICA (2019)
Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms
Leonardo Boiocchi et al.
HUMAN PATHOLOGY (2019)
Prominence of nestin-expressing Schwann cells in bone marrow of patients with myelodysplastic syndromes with severe fibrosis
Luan Cao-Sy et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level
Jiahao Chen et al.
NATURE MEDICINE (2019)
RUNX1 Mutations Can Lead to Aberrant Expression of CD79a and PAX5 in Acute Myelogenous Leukemias: A Potential Diagnostic Pitfall
Thomas Menter et al.
PATHOBIOLOGY (2019)
IKZF1 deletion and co-occurrence with other aberrations in a child with chronic myeloid leukemia progressing to acute lymphoblastic leukemia
Claudete Esteves Klumb et al.
PEDIATRIC BLOOD & CANCER (2019)
Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years
Varinder Kaur et al.
HEMATOLOGY (2018)
Clonogenic versus morphogenic mutations in myeloid neoplasms: chronologic observations in a U2AF1, TET2, CSF3R and JAK2 co-mutated' myeloproliferative neoplasm suggest a hierarchical order of mutations and potential predictive value for kinase inhibitor treatment response
Magdalena M. Gerlach et al.
LEUKEMIA & LYMPHOMA (2018)
Profile of fibrosis-related gene transcripts and megakaryocytic changes in the bone marrow of myelodysplastic syndromes with fibrosis
Kais Hussein et al.
ANNALS OF HEMATOLOGY (2018)
Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study
Helena Claerhout et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib
Arturo Bonometti et al.
HUMAN PATHOLOGY (2018)
Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations
Christophe Willekens et al.
LEUKEMIA (2018)
Acute pro-B-Cell lymphoblastic leukemia transformed from myelodysplastic syndrome with an ASXL1 missense mutation: A case report with literature review
Zhi-Ping Guo et al.
ONCOLOGY LETTERS (2018)
Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016
Alexandar Tzankov et al.
ANNALS OF HEMATOLOGY (2018)
Mutational landscape of myelodysplastic/myeloproliferative neoplasm-unclassifiable
Prithviraj Bose et al.
BLOOD (2018)
Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasms
Mrinal M. Patnaik et al.
BLOOD CANCER JOURNAL (2018)
Early detection of transformation to BPDCN in a patient with MDS
Kamal Chamoun et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2018)
BCR-ABL1 Positive B-ALL Can Undergo T-cell Lineage Shift to Become CD19 Negative T-ALL
Jolien De Bie et al.
HEMASPHERE (2018)
Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis
Ayalew Tefferi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Clinical characteristics of Philadelphia positive T-cell lymphoid leukemias-(De novo and blast phase CML)
Preetesh Jain et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
William Vainchenker et al.
BLOOD (2017)
Dynamics of clonal evolution in myelodysplastic syndromes
Hideki Makishima et al.
NATURE GENETICS (2017)
Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia
Ana Valencia-Martinez et al.
HAEMATOLOGICA (2017)
Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia
Sanam Loghavi et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2017)
Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia
Julia T. Geyer et al.
MODERN PATHOLOGY (2017)
Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases
Fabio Facchetti et al.
VIRCHOWS ARCHIV (2017)
Sharing of a PTPN11 mutation by myelodysplastic bone marrow and a mature plasmacytoid dendritic cell proliferation provides evidence for their common myelomonocytic origin
Andrea Bodmer et al.
VIRCHOWS ARCHIV (2017)
Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set
G. Goyal et al.
BLOOD CANCER JOURNAL (2017)
Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia
Ana Valencia-Martinez et al.
HAEMATOLOGICA (2017)
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Adam S. Sperling et al.
NATURE REVIEWS CANCER (2017)
Gene expression and risk of leukemic transformation in myelodysplasia
Yusuke Shiozawa et al.
BLOOD (2017)
Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapy
Inga Nagel et al.
BLOOD (2017)
Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevance
Rangit Vallapureddy et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Clonal evolution and outcomes in myelofibrosis after ruxolitinib discontinuation
Kate J. Newberry et al.
BLOOD (2017)
High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis
Matthias Papo et al.
BLOOD (2017)
Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML
Dorothee Selimoglu-Buet et al.
BLOOD (2017)
Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells
Benjamin H. Durham et al.
BLOOD (2017)
Myeloproliferative neoplasms: A decade of discoveries and treatment advances
Ayalew Tefferi
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis - a consensus-based study
Hans Michael Kvasnicka et al.
HISTOPATHOLOGY (2016)
Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms
Hongmei Li et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
J.-F. Emile et al.
BLOOD (2016)
Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment
Junaid Ansari et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations (vol 6, e415, 2016)
D. Barraco et al.
BLOOD CANCER JOURNAL (2016)
High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms
Wenting Huang et al.
ONCOTARGET (2016)
ASXL1 plays an important role in erythropoiesis
Hui Shi et al.
SCIENTIFIC REPORTS (2016)
Acute Myeloid Leukemia and Other Types of Disease Progression in Myeloproliferative Neoplasms
Magdalena Czader et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia
Michelle A. Elliott et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Histiocytic sarcoma combined with acute monocytic leukemia: a case report
Jiangning Zhao et al.
DIAGNOSTIC PATHOLOGY (2015)
DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype
Jyoti Nangalia et al.
HAEMATOLOGICA (2015)
Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma
Z. Li et al.
LEUKEMIA (2015)
Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications
Leonardo Boiocchi et al.
MODERN PATHOLOGY (2015)
Effect of Mutation Order on Myeloproliferative Neoplasms
Christina A. Ortmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors
S. Cerquozzi et al.
BLOOD CANCER JOURNAL (2015)
DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype
Jyoti Nangalia et al.
HAEMATOLOGICA (2015)
Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib
Emanuele Ammatuna et al.
ANNALS OF HEMATOLOGY (2015)
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms
Sa A. Wang et al.
BLOOD (2014)
Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia
Tiffany Y. Chang et al.
BLOOD (2014)
Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis
Raajit Rampal et al.
BLOOD (2014)
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
Pontus Lundberg et al.
BLOOD (2014)
Langerhans cell histiocytosis in acute leukemias of ambiguous or myeloid lineage in adult patients: support for a possible clonal relationship
Sophia L. Yohe et al.
MODERN PATHOLOGY (2014)
Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor
P. Brunner et al.
LEUKEMIA (2014)
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
M. M. Patnaik et al.
LEUKEMIA (2014)
Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease
Leonardo Boiocchi et al.
MODERN PATHOLOGY (2013)
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
Manja Meggendorfer et al.
BLOOD (2012)
Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome
Su-Jiang Zhang et al.
BLOOD (2012)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients
T. L. Lasho et al.
LEUKEMIA (2012)
EZH2 mutational status predicts poor survival in myelofibrosis
Paola Guglielmelli et al.
BLOOD (2011)
A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases
V. Grossmann et al.
LEUKEMIA (2011)
Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
O. Abdel-Wahab et al.
LEUKEMIA (2011)
p53 Lesions in Leukemic Transformation
Ashot Harutyunyan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms
Nils H. Thoennissen et al.
BLOOD (2010)
Histiocytic sarcoma and underlying chronic myelomonocytic leukemia: a proposal for the developmental classification of histiocytic sarcoma
Minako Mori et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1
Alexander Kohlmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
A. Tefferi et al.
LEUKEMIA (2010)
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
Myunggon Ko et al.
NATURE (2010)
Myeloid Sarcoma Extramedullary Manifestation of Myeloid Disorders
Cristina Campidelli et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Clinical Relevance of Bone Marrow Fibrosis and CD34-Positive Cell Clusters in Primary Myelodysplastic Syndromes
Matteo Giovanni Della Porta et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Sudden extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia - A nonrandom event associated with imatinib?
Annette S. Kim et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemias
Dan Jones et al.
BLOOD (2008)
Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone
Andrew L. Feldman et al.
BLOOD (2008)
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Charles G. Mullighan et al.
NATURE (2008)
A der(1;15)(q10;q10) is a rare nonrandom whole-arm translocation in patients with acute lymphoblastic leukemia
Tae Sung Park et al.
CANCER GENETICS AND CYTOGENETICS (2007)
Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis
M. A. Elliott et al.
LEUKEMIA RESEARCH (2007)
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients
S. A. Pileri et al.
LEUKEMIA (2007)
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making
L Malcovati et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
PAX5 expression in acute leukemias: Higher B-Lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia
E Tiacci et al.
CANCER RESEARCH (2004)
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
M Tartaglia et al.
NATURE GENETICS (2003)
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors
JT Hartmann et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
